🔗 IDA SENTENCE ANALYSIS
Sentence-by-sentence verification
0
Provable
1
Partly supported
2
Pending
0
Contradicted
What this page measures: whether each outward-facing statement on this article can be supported by dental research literature. Provable and partly-supported statements carry real PubMed references; pending and contradicted ones are marked only as "examined but insufficient / counter-evidence found", with no claim of support. The analysed content itself lives on source page ↗.
🔗 Sentence-by-sentence analysis (3 statements)
DNT-94896C32CAAF
到2020年，Straumann® 成為全球最大植體品牌，與國際植牙學會(ITI)緊密合作，研究驗證士卓曼植體的安全與成效。
○ Pending (insufficient evidence; no claim of support)
10 candidate paper(s) examined; evidence insufficient to support this statement; still needed: 決定性 gate 未通過；不得以檢索相似度或主題重疊升為可證明。
DNT-336E4FFE41C0
相較其他植牙品牌，Straumann®擁有長期科學數據支持且品牌在全球市佔率高，亦享有長期追蹤之保障，不用擔心淪為「植牙孤兒」，找不到可以接手的醫師。
◐ Partly supported (scope noted below)
Supported scope: Straumann（STM）植體在10年追蹤中的存活率為96.8%，因此『Straumann有長期科學數據』此一子命題有直接證據。
DNT-0AE61FCB648D
[](https://www.yuerong.com.tw/uploads/rong/images/202512101634067733.png) | **植牙初級穩定性較高、適應族群較廣**<br> BLX植體採用獨特的雙螺紋設計和先進的親水表面技術，即使在條件較不好的情況下，亦能有很好的初級穩定度。
○ Pending (insufficient evidence; no claim of support)
10 candidate paper(s) examined; evidence insufficient to support this statement; still needed: 決定性 gate 未通過；不得以檢索相似度或主題重疊升為可證明。
🗂 Related analyses (4)
🏛 View this clinic's IDA embassy →
server-rendered · verifiability = degree of literature support · idaeo-platform